Inactivation or inhibition of AcrAB-TolC increases resistance of carbapenemase-producing Enterobacteriaceae to carbapenems

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 6, 2016, Pages 1510-1519

  Saw, Howard T H ^a   Webber, Mark A ^a   Mushtaq, Shazad ^b   Woodford, Neil ^b   Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRAB PROTEIN; BACTERIAL PROTEIN; CARBAPENEM; CARBAPENEMASE; ERTAPENEM; OUTER MEMBRANE PROTEIN; PORIN; TOLC PROTEIN; UNCLASSIFIED DRUG; ACRAB-TOLC PROTEIN, E COLI; ACRAB-TOLC PROTEIN, SALMONELLA ENTERICA; ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARRIER PROTEIN; ENZYME INHIBITOR; ESCHERICHIA COLI PROTEIN; MULTIDRUG RESISTANCE PROTEIN;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENTEROBACTERIACEAE; ENZYMOLOGY; GENETICS; METABOLISM; MICROBIAL SENSITIVITY TEST; SECRETION (PROCESS); UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CARRIER PROTEINS; ENTEROBACTERIACEAE; ENZYME INHIBITORS; ESCHERICHIA COLI PROTEINS; MICROBIAL SENSITIVITY TESTS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; UNITED KINGDOM;

EID: 84973301097     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw028     Document Type: Article

References (47)

1. WHO. Antimicrobial Resistance-Global Report on Surveillance. http:// apps.who.int/iris/bitstream/10665/112642/1/9789241564748_eng.pdf.
2. Piddock LJV. The crisis of no new antibiotics-what is the way forward? Lancet Infect Dis 2012; 12: 249-53.
3. Papp-Wallace KM, Endimiani A, Taracila MA et al. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011; 55: 4943-60.
4. Jean SS, Lee WS, LamC et al. Carbapenemase-producing Gram-negative bacteria: current epidemics, antimicrobial susceptibility and treatment options. Future Microbiol 2015; 10: 407-25.
5. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 2014; 44: 51-6.
6. Bratu S, Mooty M, Nichani S et al. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 2005; 49:3018-20.
7. Landman D, Salamera J, SinghM et al. Accuracy of carbapenem nonsusceptibility for identification of KPC-possessing Enterobacteriaceae by use of the revised CLSI breakpoints. J Clin Microbiol 2011; 49: 3931-3.
8. Landman D, Urban C, Bäcker M et al. Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinity. J Clin Microbiol 2010; 48: 4604-7.
9. Kitchel B, Rasheed JK, Endimiani A et al. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54: 4201-7.
10. Tsai YK, Fung CP, Lin JC et al. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 2011; 55: 1485-93.
11. Landman D, Bratu S, Quale J. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 2009; 58: 1303-8.
12. Piddock LJV. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 2006; 19: 382-402.
13. Pages J-M, Lavigne J-P, Leflon-Guibout Vet al. Efflux pump, the masked side of ß-lactam resistance in Klebsiella pneumoniae clinical isolates. PLoS One 2009; 4: e4817.
14. Opperman TJ, Kwasny SM, Kim HS et al. Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli. Antimicrob Agents Chemother 2014; 58: 722-33.
15. McMurry LM, Oethinger M, Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett 1998; 166: 305-9.
16. Oethinger M, Kern WV, Jellen-Ritter AS et al. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother 2000; 44: 10-3.
17. Ricci V, Tzakas P, Buckley A et al. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob Agents Chemother 2006; 50: 38-42.
18. Datsenko KA,Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 2000; 97:6640-5.
19. Cottell JL, Saw HTH, Webber MA et al. Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid. BMC Microbiol 2014; 14: 168.
20. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother 2001; 48 Suppl 1: 5-16.
21. Piddock LJV, Traynor EA, Wise R. A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae. J Antimicrob Chemother 1990; 26: 749-62.
22. Doumith M, Ellington MJ, Livermore DM et al. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 2009; 63: 659-67.
23. Jain A, Hopkins KL, Turton J et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother 2014; 69: 1777-84.
24. Pournaras S, Kristo I, Vrioni G et al. Characteristics of meropenem heteroresistance in Klebsiella pneumoniae carbapenemase (KPC)-producing clinical isolates of K. pneumoniae. J Clin Microbiol 2010; 48: 2601-4.
25. Zavascki AP, Falci DR, Da Silva RCF et al. Heteroresistance to carbapenems in NewDelhi metallo-b-lactamase-1-producing isolates: a challenge for detection? Infect Control Hosp Epidemiol 2014; 35: 751-2.
26. Baroud M, Dandache I, Araj GF et al. Underlying mechanisms of carbapenem resistance in extended-spectrum b-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents 2013; 41: 75-9.
27. Szabó D, Silveira F, Hujer AM et al. Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob Agents Chemother 2006; 50: 2833-5.
28. Yang FC, Yan JJ, Hung KH et al. Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese University Hospital. J Clin Microbiol 2012; 50: 223-6.
29. Kinana AD, Vargiu AV, Nikaido H. Some ligands enhance the efflux of other ligands by the Escherichia coli multidrug pump AcrB. Biochemistry 2013; 52: 8342-51.
30. Lamers RP, Cavallari JF, Burrows LL. The efflux inhibitor phenylalaninearginine b-naphthylamide (PAbN) permeabilizes the outer membrane of Gram-negative bacteria. PLoS One 2013; 8: e60666.
31. Matsumoto Y, Hayama K, Sakakihara S et al. Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS One 2011; 6: e18547.
32. Barbosa TM, Levy SB. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 2000; 182: 3467-74.
33. De Majumdar S, Veleba M, Finn S et al. Elucidating the regulon of multidrug resistance regulator rarA in Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 1603-9.
34. Webber MA, Bailey AM, Blair JMA et al. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host. J Bacteriol 2009; 191: 4276-85.
35. De La Cruz MA, Calva E. The complexities of porin genetic regulation. J Mol Microbiol Biotechnol 2010; 18: 24-36.
36. Martínez-Flores I, Cano R, Bustamante VH et al. The ompB operon partially determines differential expression of OmpC in Salmonella typhi and Escherichia coli. J Bacteriol 1999; 181: 556-62.
37. Pagès J-M, Amaral L. Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria. Biochim Biophys Acta 2009; 1794: 826-33.
38. Ho PL, Lo WU, Yeung MK et al. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One 2011; 6:e17989.
39. Teale CJ, Barker L, Foster AP et al. Extended-spectrum b-lactamase detected in E. coli recovered from calves in Wales. Vet Rec 2005; 156: 186-7.
40. Norrander J, Kempe T, Messing J. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene 1983; 26: 101-6.
41. Forage RG, Lin ECC. dha System mediating aerobic and anaerobic dissimilation of glycerol in Klebsiella pneumoniae NCIB 418. J Bacteriol 1982; 151: 591-9.
42. Veleba M, Higgins PG, Gonzalez G et al. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob Agents Chemother 2012; 56: 4450-8.
43. Baba T, Ara T, Hasegawa M et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol Syst Biol 2006; 2.
44. Nishino K, Latifi T, Groisman EA. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol Microbiol 2006; 59: 126-41.
45. Wray C, Sojka WJ. Experimental Salmonella Typhimurium infection in calves. Res Vet Sci 1978; 25: 139-43.
46. Blair JM, La Ragione RM, Woodward MJ et al. Periplasmic adaptor protein AcrA has a distinct role in the antibiotic resistance and virulence of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother 2009; 64: 965-72.
47. Buckley AM,Webber MA, Cooles S et al. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimuriumplays a role in pathogenesis. Cell Microbiol 2006; 8: 847-56.